GSGPX
Price
$10.84
Change
-$0.08 (-0.73%)
Updated
Nov 13 closing price
Net Assets
5.54B
RYMSX
Price
$25.01
Change
-$0.10 (-0.40%)
Updated
Nov 13 closing price
Net Assets
11.76M
Interact to see
Advertisement

GSGPX vs RYMSX

Header iconGSGPX vs RYMSX Comparison
Open Charts GSGPX vs RYMSXBanner chart's image
Goldman Sachs Absolute Ret Trckr P
Price$10.84
Change-$0.08 (-0.73%)
VolumeN/A
Net Assets5.54B
Guggenheim Multi-Hedge Strategies P
Price$25.01
Change-$0.10 (-0.40%)
VolumeN/A
Net Assets11.76M
GSGPX vs RYMSX Comparison Chart in %
View a ticker or compare two or three
VS
GSGPX vs. RYMSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGPX is a Hold and RYMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSGPX has more cash in the bank: 5.54B vs. RYMSX (11.8M). RYMSX pays higher dividends than GSGPX: RYMSX (2.87) vs GSGPX (1.05). GSGPX was incepted earlier than RYMSX: GSGPX (8 years) vs RYMSX (20 years). RYMSX (2.12) is less costly to investors than GSGPX (0.82). GSGPX is a more actively managed with annual turnover of: 179.00 vs. RYMSX (164.00). GSGPX (0) and RYMSX (0) have matching initial minimum investment requirements. GSGPX annual gain was more profitable for investors over the last year : 8.34 vs. RYMSX (-1.38). GSGPX return over 5 years is better than : 19.94 vs. RYMSX (7.09).
GSGPXRYMSXGSGPX / RYMSX
Total Expense Ratio0.732.0635%
Annual Report Gross Expense Ratio0.822.1239%
Fund Existence8 years20 years-
Gain YTD8.7260.924944%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.54B11.8M46,941%
Annual Yield % from dividends1.052.8737%
Returns for 1 year8.34-1.38-603%
Returns for 3 years27.191.332,043%
Returns for 5 years19.947.09281%
Returns for 10 yearsN/A17.00-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MET80.212.42
+3.11%
MetLife
ELMD25.380.27
+1.08%
Electromed
KYMR63.530.16
+0.25%
Kymera Therapeutics
NTCL1.11N/A
N/A
Netclass Technology Inc
TMP67.79-0.34
-0.50%
Tompkins Financial Corp